BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $97 at Oppenheimer
August 7, 2026 6:17 AM
Oppenheimer analyst Leland Gershell raised the price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $97.00 (from $95.00) while maintaining ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
